Results 31 to 40 of about 257 (91)
Abstract Aims/Introduction Peroxisome proliferator activated receptor gamma (PPARG) is a nuclear hormone receptor of the ligand‐dependent transcription factor involved in adipogenesis, and a molecular target of the insulin sensitizer, thiazolidinediones.
Arup Kumar Pattanayak +5 more
wiley +1 more source
BACKGROUND: Half of all patients with chronic heart failure (CHF) have preserved ejection fraction (CHF-nEF). The drug’s use effective for treatment of CHF with reduced ejection fraction (CHF-nFV) reduces the hospitalization incidence but does not affect
T. S. Sveklina +6 more
doaj +1 more source
Background and Aims: Similar clinical and pathological features have been observed in Alzheimer's disease (AD) and Parkinson's disease with dementia (PDD).
Nobuto Shibata +9 more
doaj +1 more source
Chronic kidney disease (CKD) is well known as a strong risk factor for both end stage renal disease and cardiovascular disease. To clarify the association of polymorphisms in the PPAR genes (PPARD, PPARG, and PPARGC1A) with the risk of CKD in Japanese, we examined this association among the Japanese subjects using the cross‐sectional data of J‐MICC ...
Asahi Hishida +17 more
wiley +1 more source
The Impact of PPARγ Genetic Variants on IBD Susceptibility and IBD Disease Course
PPARγ is a nuclear receptor that regulates numerous pathways including cytokine expression and immune responses and plays an important role in controlling colon inflammation. We aimed at determining the occurring PPARγ SNPs, at predicting the haplotypes, and at determining the frequency outcome in inflammatory bowel disease (IBD) patients in comparison
Jessica Mwinyi +4 more
wiley +1 more source
Introduction Peroxisome proliferator-activated receptor gamma (PPARG) gene polymorphisms, particularly rs1801282 (Pro12Ala) and rs3856806 (C161T), have been implicated in obesity, but findings remain inconsistent across populations.
Shobha C Ramachandra +4 more
doaj +1 more source
Genetic Variability of RXRB, PPARA, and PPARG in Wegener′s Granulomatosis
A major genomic region involved in Wegener′s granulomatosis includes the gene for retinoid receptor beta (RXRB) which forms heterodimers with peroxisome proliferator‐activated receptors (PPARs). It is unclear whether this association directly arises from the RXRB allele(s) or via a linked variation.
Stefan Wieczorek +4 more
wiley +1 more source
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease
The peroxisome proliferator‐activated receptors (PPARs) consist of three related transcription factors that serve to regulate a number of cellular processes that are central to cardiovascular health and disease. Numerous pharmacologic studies have assessed the effects of specific PPAR agonists in clinical trials and have provided insight into the ...
Sharon Cresci, Giulia Chinetti
wiley +1 more source
The Genetics of PPARG and the Skeleton
Osteoporosis is a complex metabolic bone disorder. Recently it has been appreciated that the “obesity in bone” phenomenon occurs at the expense of bone formation, and that is a key component of the pathology of this disease. Mouse models with altered bone expression levels of peroxisome proliferator‐activated receptor gamma (PPARG) impact bone ...
Cheryl Ackert-Bicknell, Clifford Rosen
wiley +1 more source
Effects of the PPARG gene polymorphisms on markers of obesity and the metabolic syndrome in Bosnian subjects [PDF]
Background: Peroxisome proliferator-activated receptor gamma (PPARg) is a key transcription factor in adipogenesis, and also regulates a number of genes associated with lipid storage and insulin sensitivity.
Dujić Tanja +8 more
doaj

